Literature DB >> 22127462

Increased levels of the high mobility group box 1 protein sustain the inflammatory bone marrow microenvironment in patients with chronic idiopathic neutropenia via activation of toll-like receptor 4.

Maria Velegraki1, Helen Koutala, Christos Tsatsanis, Helen A Papadaki.   

Abstract

PURPOSE: Chronic idiopathic neutropenia (CIN) is a granulocytic disorder characterized by increased apoptosis of the bone marrow (BM) granulocytic progenitor cells and an inflammatory BM microenvironment. The aim of this study was to investigate the possible involvement of Toll-like receptors (TLRs) in the production of pro-inflammatory mediators in CIN BM.
METHODS: We evaluated the expression of TLRs in patient BM cell subsets and adherent cells of long-term BM cultures (LTBMCs) using flow cytometry. We also examined the activation of TLR-mediated signaling using real-time PCR arrays and explored for potential endogenous TLR-specific ligands in CIN BM.
RESULTS: CIN patients (n = 30) displayed significantly increased expression of surface TLR4 in monocytes of BM and LTBMC adherent cells compared to controls (n = 27). The TLR signaling gene array study in purified BM CD14(+) cells showed that numerous TLR-related genes displayed at least two-fold increase in patients compared to controls. Among the over-expressed genes were genes related to the MyD88-dependent and MyD88-independent pathway suggesting a TLR4-mediated signaling. BM plasma from CIN patients induced the production of pro-inflammatory mediators including interleukin (IL)-6, IL-1β, tumor necrosis factor-α, and IL-8 by autologous BM monocytes, and this effect was abrogated by a specific TLR4 inhibitor. The levels of the high mobility group box 1 protein (HMGB1), representing a TLR4 ligand, were significantly increased in patient LTBMC supernatants compared to controls.
CONCLUSION: These data demonstrate a significant role of BM monocytes in the pathophysiology of CIN through the production of pro-inflammatory cytokines in a TLR4-mediated mechanism under the influence of endogenous ligands such as HMGB1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127462     DOI: 10.1007/s10875-011-9620-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

Review 1.  Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.

Authors:  Helena Erlandsson Harris; Ulf Andersson
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

Review 2.  Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.

Authors:  Xiaoyu Hu; Janice Chen; Lu Wang; Lionel B Ivashkiv
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

3.  Chronic neutropenia.

Authors:  D C Dale; D Guerry; J R Wewerka; J M Bull; M J Chusid
Journal:  Medicine (Baltimore)       Date:  1979-03       Impact factor: 1.889

4.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.

Authors:  Huan Yang; Hulda S Hreggvidsdottir; Karin Palmblad; Haichao Wang; Mahendar Ochani; Jianhua Li; Ben Lu; Sangeeta Chavan; Mauricio Rosas-Ballina; Yousef Al-Abed; Shizuo Akira; Angelika Bierhaus; Helena Erlandsson-Harris; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 5.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

6.  Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells.

Authors:  H A Papadaki; K Giouremou; G D Eliopoulos
Journal:  Eur J Haematol       Date:  1999-09       Impact factor: 2.997

7.  Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.

Authors:  Christos I Maratheftis; Evangelos Andreakos; Haralampos M Moutsopoulos; Michael Voulgarelis
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

Review 8.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

9.  Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells.

Authors:  Helen A Papadaki; Aristides G Eliopoulos; Theodoros Kosteas; Claudia Gemetzi; Athina Damianaki; Helen Koutala; Juergen Bux; George D Eliopoulos
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

Review 10.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

Authors:  David S Pisetsky; Helena Erlandsson-Harris; Ulf Andersson
Journal:  Arthritis Res Ther       Date:  2008-06-30       Impact factor: 5.156

View more
  7 in total

1.  Genomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1.

Authors:  Ashok R Amin; Abul B M M K Islam
Journal:  DNA Cell Biol       Date:  2014-06-06       Impact factor: 3.311

2.  Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production.

Authors:  Maria Velegraki; Evaggelia Papakonstanti; Irene Mavroudi; Maria Psyllaki; Christos Tsatsanis; Anastasis Oulas; Ioannis Iliopoulos; Pavlos Katonis; Helen A Papadaki
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

Review 3.  Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review.

Authors:  Li-Feng Huang; Yong-Ming Yao; Zhi-Yong Sheng
Journal:  World J Emerg Med       Date:  2012

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway.

Authors:  Longhui Han; Minglian Zhang; Mengmeng Wang; Jinchen Jia; Miying Zhao; Yiming Fan; Xiaorong Li
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

6.  A Genome-wide Association Study Provides Evidence of Sex-specific Involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) With Diabetic Neuropathic Pain.

Authors:  Weihua Meng; Harshal A Deshmukh; Louise A Donnelly; Nicola Torrance; Helen M Colhoun; Colin N A Palmer; Blair H Smith
Journal:  EBioMedicine       Date:  2015-08-04       Impact factor: 8.143

Review 7.  Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2012-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.